Evidence map›Paper›PMID 28705819›Full record

ArticleAJNR. American journal of neuroradiology2017

MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia?

S Shams, D Fällmar, S Schwarz, L-O Wahlund, D van Westen, O Hansson, E-M Larsson, S Haller

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in AJNR. American journal of neuroradiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 6 countries.

S ShamsFrom the Department of Clinical Science, Intervention, and Technology (S. Shams), Division of Medical Imaging and Technology sara.shams@ki.se.ORCID http://orcid.org/0000-0002-5133-0224
D FällmarDepartment of Surgical Sciences (D.F., E.-M.L.), Department of Radiology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-5615-2036
S SchwarzRadiological Sciences (S. Schwarz), Division of Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.ORCID http://orcid.org/0000-0002-9019-4755
L-O WahlundDepartment of Neurobiology, Care Sciences, and Society (L.-O.W.), Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-9905-8426
D van WestenDepartment of Radiology (E.-M.L., D.v.W.).ORCID http://orcid.org/0000-0001-8649-9874
O HanssonMemory Clinic (O.H.), Skåne University Hospital and Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0001-8467-7286
E-M LarssonDepartment of Surgical Sciences (D.F., E.-M.L.), Department of Radiology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-6308-1387
S HallerAffidea CDRC Centre de Diagnostic Radiologique de Carouge SA (S.H.), Carouge GE, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-7433-0203
Uppsala University · SEAin Shams University · EGInstitution Genevoise de Maintien à Domicile · CHKarolinska University Hospital · SELund University · SENeurology, Inc · USUniversity of Nottingham · GB

Funding

Parkinson's UK J-1204
6 · The paper itself

Abstract

background and purposeThere are, to date, no MR imaging diagnostic markers for Lewy body dementia. Nigrosome 1, containing dopaminergic cells, in the substantia nigra pars compacta is hyperintense on SWI and has been called the swallow tail sign, disappearing with Parkinson disease. We aimed to study the swallow tail sign and its clinical applicability in Lewy body dementia and hypothesized that the sign would be likewise applicable in Lewy body dementia. MATERIALS AND

methodsThis was a retrospective cross-sectional multicenter study including 97 patients (mean age, 65 ± 10 years; 46% women), consisting of the following: controls (

resultsInterrater agreement was moderate (κ = 0.4) between raters. An abnormal swallow tail sign was most common in Lewy body dementia (63%; 95% CI, 41%-85%;

conclusionsThe swallow tail sign has diagnostic potential in Lewy body dementia and may be a complement in the diagnostic work-up of this condition.

Indexed as

AgedCross-Sectional StudiesDopaminergic NeuronsFemaleHumansLewy Body DiseaseMagnetic Resonance ImagingMaleMiddle AgedRetrospective Studies

Identifiers

PMID28705819
PMCPMC7963704
OpenAlexW2735587045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.